Hum; Dean

Patent Applications and Registrations

Patent applications and USPTO patent grants for Hum; Dean.The latest application filed is for "use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders".

Company Profile

6.11.12

Hum; Dean - Bondues FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical compositions for combination therapy Grant 11,191,749 - Hum , et al. December 7, 2	2021-12-07
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20200384105 - DARTEIL; Raphael ; et al.	2020-12-10
Methods of treatment of fibrosis and cancers Grant 10,792,277 - Hanf , et al. October 6, 2	2020-10-06
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 10,722,575 - Darteil , et al.	2020-07-28
Pharmaceutical Compositions For Combination Therapy App 20200061028 - HUM; Dean ; et al.	2020-02-27
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20190275146 - Darteil; Raphael ; et al.	2019-09-12
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 10,350,181 - Darteil , et al. July 16, 2	2019-07-16
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20180280328 - DARTEIL; Raphael ; et al.	2018-10-04
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 10,022,343 - Darteil , et al. July 17, 2	2018-07-17
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20170368007 - DARTEIL; Raphael ; et al.	2017-12-28
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 9,782,373 - Darteil , et al. October 10, 2	2017-10-10
Methods Of Treatment Of Fibrosis And Cancers App 20170239213 - HANF; Remy ; et al.	2017-08-24
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20170128399 - DARTEIL; Raphael ; et al.	2017-05-11
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 9,585,853 - Darteil , et al. March 7, 2	2017-03-07
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20160051501 - DARTEIL; Raphael ; et al.	2016-02-25
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 9,221,751 - Darteil , et al. December 29, 2	2015-12-29
Methods Of Treatment Of Fibrosis And Cancers App 20150352065 - HANF; Remy ; et al.	2015-12-10
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20150051145 - DARTEIL; Raphael ; et al.	2015-02-19
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 8,895,619 - Darteil , et al. November 25, 2	2014-11-25
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20140309165 - DARTEIL; Raphael ; et al.	2014-10-16
Use of 1,3-diphenylprop-2-en-1-one derivatives for treating liver disorders Grant 8,772,342 - Darteil , et al. July 8, 2	2014-07-08
Use Of 1,3-diphenylprop-2-en-1-one Derivatives For Treating Liver Disorders App 20120252725 - Darteil; Raphael ; et al.	2012-10-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.